NCT01194518

Brief Summary

to compare the effectiveness of tailored TTM-based interventions (intervention group) compared to usual care (control group) on biomarkers of kidney function, physical indicators, adoption of health-promoting lifestyle behaviors, kidney disease knowledge, perceived self-efficacy, perceived benefits and barriers to physical activity changes, and quality of life among patients with early-stage CKD over a 30 month period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 31, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 3, 2010

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
12.7 years until next milestone

Results Posted

Study results publicly available

May 28, 2026

Completed
Last Updated

May 28, 2026

Status Verified

January 1, 2023

Enrollment Period

2.9 years

First QC Date

August 31, 2010

Results QC Date

October 9, 2014

Last Update Submit

May 3, 2026

Conditions

Keywords

Chronic kidney diseasehealth-promotingrandomized controlled trialtailored interventiontranstheoretical model

Outcome Measures

Primary Outcomes (12)

  • The Results of eGFR at Each Time Poins From Baseline to 6, 12, 18, 24, and 30 Months

    The eGFR was estimated using the Modification of Diet in Renal Disease (MDRD) formula (eGFR (ml/min/1.73 m2) = 186 Ă— (SCr)-1.154 Ă— (Age)-0.203 Ă— (0.742 if female) (National Kidney Foundation, 2002). The results were presented at each time point from baseline to 6, 12,18,24, and 30 months after follow-up data.

    The baseline and at 6, 12, 18, 24, and 30 months post intervention

  • The Results of Waist Circumference From Baseline to 6, 12, 18, 24, and 30 Months

    Waist circumference in centimeters was measured at the level midway between the lowest rib margin and the iliac crest at baseline, 6, 12, 18, 24, and 30 months for each intervention. The results were presented at each time point from baseline to 6, 12,18,24, and 30 months after follow-up data.

    The baseline and at 6, 12, 18, 24, and 30 months post intervention

  • The Results of Hip Circumference From Baseline to 6, 12, 18, 24, and 30 Months

    Hip circumference was measured at the widest area over the trochanters at 6, 12, 18, 24, and 30 months of every intervention. The results were presented at each time point from baseline to 6, 12,18,24, and 30 months after follow-up data.

    The baseline and at 6, 12, 18, 24, and 30 months post intervention

  • The Results of Health Promotion Lifestyle Behaviors Scales Total Scores From Baseline to 6, 12, 18, 24, and 30 Months

    The HPLP-II is validated, Self-report questionnaires Health promotion lifestyle was measured by the 52-item Health-Promoting Lifestyle-II (HPLP-II) Chinese questionnaire. The total scores of the HPLP-II are determined by calculating a mean item response. The HPLP-II uses mean sums of scale items to remain the 1 to 4 metric of item. Higher scores indicated better health-promoting lifestyle behaviors. The results were presented at each time point from baseline to 6, 12,18,24, and 30 months after follow-up data.

    The baseline and at 6, 12, 18, 24, and 30 months post intervention

  • The Results of Disease-specific Knowledge of Renal Protection Checklist (RPK) Scales Total Scores From Baseline to 6, 12, 18, 24, and 30 Months

    The renal protection checklist (RPK) is validated, Self-report questionnaires a disease-specific knowledge of renal protection checklist were developed by Yen, Huang, and Teng in 2008. The checklist consists of 20 items including three domains: renal function protection (11 items), knowledge of Chinese herbal medicine related to renal function (5 items), and diet with CKD (4 items). Item responses were "true" or "false." Each item is scored with 5 points for each correct answer. The total scores for the checklist range from 0-100. Higher scores indicate higher knowledge of renal function protection. The results were presented at each time point from baseline to 6, 12,18,24, and 30 months after follow-up data.

    The baseline and at 6, 12, 18, 24, and 30 months post intervention

  • The Results of Physical Health QOL Scores From Baseline to 12, and 24 Months

    The WHOQOL-BREF Taiwanese version is validated, as Self-report questionnaires. The WHOQOL-BREF Taiwanese version was evaluated using 26 items. The WHOQOL-BREF Taiwanese version incorporates four domains: physical health (7 items), psychological health (6 items), social relationships (4 items), and environment (9 items). Using a 5-point Likert scale from 1 "not satisfied at all" to 5 "extremely satisfied", higher scores indicate a better QOL. Each domain's score ranged from 4 to 20, which was calculated by multiplying the average of the scores of all items in the domain by four. The results presented the physical health QOL scores at each time point from baseline to 12, and 24 months.

    The baseline and at 12, 24 months post intervention

  • The Results of Psychological Health QOL Scores From Baseline to 12, and 24 Months

    The WHOQOL-BREF Taiwanese version is validated, as Self-report questionnaires. The WHOQOL-BREF Taiwanese version was evaluated using 26 items. The WHOQOL-BREF Taiwanese version incorporates four domains: physical health (7 items), psychological health (6 items), social relationships (4 items), and environment (9 items). Using a 5-point Likert scale from 1 "not satisfied at all" to 5 "extremely satisfied", higher scores indicate a better QOL. Each domain's score ranged from 4 to 20, which was calculated by multiplying the average of the scores of all items in the domain by four. The results present the psychological health QOL scores from baseline to 12, and 24 Months.

    The baseline and at 12, 24 months post intervention

  • The Results of Social Relationships QOL Scores From Baseline to 12, and 24 Months.

    The WHOQOL-BREF Taiwanese version is validated, as Self-report questionnaires. The WHOQOL-BREF Taiwanese version was evaluated using 26 items. The WHOQOL-BREF Taiwanese version incorporates four domains: physical health (7 items), psychological health (6 items), social relationships (4 items), and environment (9 items). Using a 5-point Likert scale from 1 "not satisfied at all" to 5 "extremely satisfied", higher scores indicate a better QOL. Each domain's score ranged from 4 to 20, which was calculated by multiplying the average of the scores of all items in the domain by four. The results present the Social Relationships QOL scores at each time point from baseline to 12, and 24 months.

    The baseline and at 12, 24 months post intervention

  • The Results of Environment QOL Scores From Baseline to 12, and 24 Months

    The WHOQOL-BREF Taiwanese version is validated, as Self-report questionnaires. The WHOQOL-BREF Taiwanese version was evaluated using 26 items. The WHOQOL-BREF Taiwanese version incorporates four domains: physical health (7 items), psychological health (6 items), social relationships (4 items), and environment (9 items). Using a 5-point Likert scale from 1 "not satisfied at all" to 5 "extremely satisfied", higher scores indicate a better QOL. Each domain's score ranged from 4 to 20, which was calculated by multiplying the average of the scores of all items in the domain by four. The results present the Environment QOL scores at each time point from baseline to 12, 24 months.

    The baseline and at 12, 24 months post intervention

  • The Results of Perceived Self-efficacy of Physical Activity Scores From Baseline to 12, and 24 Months

    The Perceived self-efficacy of physical activity is validated, and the Self-report questionnaire. The perceived self-efficacy scale was used to measure perceived self-efficacy for physical activity. Fifteen items are answered on a six-point Likert scale ranging from 1 (completely uncertain) to 6 (completely certain). The total score ranges from 15-90, with a higher score representing greater perceived self-efficacy for physical activity. The results present the Perceived self-efficacy of physical activity scores at each time point from baseline to 12, and 24 months.

    The baseline and at 12, 24 months post intervention

  • The Results of Decisional Balance (Perceived Benefits of Physical Activity) Scores From Baseline to 12, and 24 Months

    The Decisional Balance Scale measures the perceived benefits and barriers of physical activity on a 6-point Likert scale ranging from 1 (strongly disagree) to 6 (strongly agree). The scale of the benefits of changing physical activity behaviors (14 items) and the total score range from 14-84. The higher the scores represent the perceived benefits of physical activity is higher. The results present the Decisional balance (perceived benefits of physical activity) scores at each time point from baseline to 12, and 24 months.

    The baseline and at 12, 24 months post intervention

  • The Results of Decisional Balance (Perceived Barrier of Physical Activity) From Baseline to 12, and 24 Months

    The Decisional Balance Scale measures the perceived benefits and barriers of physical activity on a 6-point Likert scale ranging from 1 (strongly disagree) to 6 (strongly agree). The scale of the barrier of changing physical activity behaviors (15 items) and the total score range from 15-90. The higher the scores represent the perceived barrier to physical activity is higher. The results present the Decisional Balance (Perceived Barrier of Physical Activity) scores at each time point from baseline to 12, and 24 months.

    The baseline and at 12, 24 months post intervention

Study Arms (2)

Intervention group

EXPERIMENTAL

Intervention groups completed the stage-of-change and readiness-to-change assessments. Intervention groups were provided tailored interventions based on the premise that patient response to physical activity in stages for lifestyle counseling from baseline, 6, 12,18 24, and 30 months.

Behavioral: Lifestyle counseling Program

Control group

NO INTERVENTION

Control group only received usual care.

Interventions

The tailored intervention made use of the 10 processes of change, important guides for developing intervention programs, which have received the most empirical support to date. The 10 processes include consciousness raising, dramatic relief, self-reevaluation, environmental reevaluation, self-liberation, social liberation, counterconditioning, stimulus control, reinforcement management, and helping relations. The different tailored interventions were based on the processes of change matched to the patient's stage of change, providing strategies that may be especially helpful to patients. According to the Lenio analysis of the TTM model of behavior change, the first five processes are used in the early stages, and the last five are used in the later stages.

Also known as: tailored interventions
Intervention group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • at least 20 years old 2. diagnosed as stage 1-3 CKD (eGFR greater than ≧ 44 ml/min per 1.73 m2), 3. spoke Mandarin, 4.could be followed up every 6 months when they returned for a clinic outpatient visit.

You may not qualify if:

  • could not participate in moderate exercise
  • not able to verbalize understanding of the study
  • already enrolled in another program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cheng Kung University

Tainan, 70101, Taiwan

Location

Related Publications (34)

  • Araujo-Soares V, Hankonen N, Presseau J, Rodrigues A, Sniehotta FF. Developing Behavior Change Interventions for Self-Management in Chronic Illness: An Integrative Overview. Eur Psychol. 2019;24(1):7-25. doi: 10.1027/1016-9040/a000330. Epub 2018 Aug 16.

    PMID: 31496632BACKGROUND
  • Barzin M, Hosseinpanah F, Serahati S, Salehpour M, Nassiri AA, Azizi F. Changes in waist circumference and incidence of chronic kidney disease. Eur J Clin Invest. 2014 May;44(5):470-6. doi: 10.1111/eci.12253.

    PMID: 24580088BACKGROUND
  • Chang PY, Chien LN, Lin YF, Wu MS, Chiu WT, Chiou HY. Risk factors of gender for renal progression in patients with early chronic kidney disease. Medicine (Baltimore). 2016 Jul;95(30):e4203. doi: 10.1097/MD.0000000000004203.

    PMID: 27472690BACKGROUND
  • Chen YC, Lai SH, Tsai YW, Chang SS. Visceral Adiposity Index as a Predictor of Chronic Kidney Disease in a Relatively Healthy Population in Taiwan. J Ren Nutr. 2018 Mar;28(2):91-100. doi: 10.1053/j.jrn.2017.07.006. Epub 2017 Nov 14.

    PMID: 29146142BACKGROUND
  • Chen SH, Tsai YF, Sun CY, Wu IW, Lee CC, Wu MS. The impact of self-management support on the progression of chronic kidney disease--a prospective randomized controlled trial. Nephrol Dial Transplant. 2011 Nov;26(11):3560-6. doi: 10.1093/ndt/gfr047. Epub 2011 Mar 17.

    PMID: 21414969BACKGROUND
  • Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014 Jun 25;311(24):2518-2531. doi: 10.1001/jama.2014.6634.

    PMID: 24892770BACKGROUND
  • Fischer F, Lange K, Klose K, Greiner W, Kraemer A. Barriers and Strategies in Guideline Implementation-A Scoping Review. Healthcare (Basel). 2016 Jun 29;4(3):36. doi: 10.3390/healthcare4030036.

    PMID: 27417624BACKGROUND
  • Fung E, Kurella Tamura M. Epidemiology and Public Health Concerns of CKD in Older Adults. Adv Chronic Kidney Dis. 2016 Jan;23(1):8-11. doi: 10.1053/j.ackd.2015.10.001.

    PMID: 26709057BACKGROUND
  • GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.

    PMID: 32061315BACKGROUND
  • Hsu CC, Hwang SJ, Wen CP, Chang HY, Chen T, Shiu RS, Horng SS, Chang YK, Yang WC. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis. 2006 Nov;48(5):727-38. doi: 10.1053/j.ajkd.2006.07.018.

    PMID: 17059992BACKGROUND
  • Jha V, Modi GK. Getting to know the enemy better-the global burden of chronic kidney disease. Kidney Int. 2018 Sep;94(3):462-464. doi: 10.1016/j.kint.2018.05.009. Epub 2018 Aug 3.

    PMID: 30078513BACKGROUND
  • Lee MC, Wu SV, Hsieh NC, Tsai JM. Self-Management Programs on eGFR, Depression, and Quality of Life among Patients with Chronic Kidney Disease: A Meta-Analysis. Asian Nurs Res (Korean Soc Nurs Sci). 2016 Dec;10(4):255-262. doi: 10.1016/j.anr.2016.04.002. Epub 2016 May 13.

    PMID: 28057311BACKGROUND
  • Lopez-Vargas PA, Tong A, Howell M, Craig JC. Educational Interventions for Patients With CKD: A Systematic Review. Am J Kidney Dis. 2016 Sep;68(3):353-70. doi: 10.1053/j.ajkd.2016.01.022. Epub 2016 Mar 26.

    PMID: 27020884BACKGROUND
  • Luyckx VA, Tuttle KR, Garcia-Garcia G, Gharbi MB, Heerspink HJL, Johnson DW, Liu ZH, Massy ZA, Moe O, Nelson RG, Sola L, Wheeler DC, White SL. Reducing major risk factors for chronic kidney disease. Kidney Int Suppl (2011). 2017 Oct;7(2):71-87. doi: 10.1016/j.kisu.2017.07.003. Epub 2017 Sep 20.

    PMID: 30675422BACKGROUND
  • McCoy CE. Understanding the Intention-to-treat Principle in Randomized Controlled Trials. West J Emerg Med. 2017 Oct;18(6):1075-1078. doi: 10.5811/westjem.2017.8.35985. Epub 2017 Sep 18.

    PMID: 29085540BACKGROUND
  • Michishita R, Matsuda T, Kawakami S, Tanaka S, Kiyonaga A, Tanaka H, Morito N, Higaki Y. The association between changes in lifestyle behaviors and the incidence of chronic kidney disease (CKD) in middle-aged and older men. J Epidemiol. 2017 Aug;27(8):389-397. doi: 10.1016/j.je.2016.08.013. Epub 2017 Apr 3.

    PMID: 28385348BACKGROUND
  • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266. No abstract available.

    PMID: 11904577BACKGROUND
  • Nguyen NT, Douglas C, Bonner A. Effectiveness of self-management programme in people with chronic kidney disease: A pragmatic randomized controlled trial. J Adv Nurs. 2019 Mar;75(3):652-664. doi: 10.1111/jan.13924. Epub 2019 Feb 14.

    PMID: 30537153BACKGROUND
  • Nojima J, Meguro S, Ohkawa N, Furukoshi M, Kawai T, Itoh H. One-year eGFR decline rate is a good predictor of prognosis of renal failure in patients with type 2 diabetes. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(9):746-754. doi: 10.2183/pjab.93.046.

    PMID: 29129852BACKGROUND
  • Pagels AA, Soderkvist BK, Medin C, Hylander B, Heiwe S. Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment. Health Qual Life Outcomes. 2012 Jun 18;10:71. doi: 10.1186/1477-7525-10-71.

    PMID: 22710013BACKGROUND
  • Peng S, He J, Huang J, Lun L, Zeng J, Zeng S, Zhang L, Liu X, Wu Y. Self-management interventions for chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol. 2019 Apr 26;20(1):142. doi: 10.1186/s12882-019-1309-y.

    PMID: 31027481BACKGROUND
  • Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983 Jun;51(3):390-5. doi: 10.1037//0022-006x.51.3.390. No abstract available.

    PMID: 6863699BACKGROUND
  • Prochaska JO, Velicer WF, Rossi JS, Goldstein MG, Marcus BH, Rakowski W, Fiore C, Harlow LL, Redding CA, Rosenbloom D, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994 Jan;13(1):39-46. doi: 10.1037//0278-6133.13.1.39.

    PMID: 8168470BACKGROUND
  • Richards KC, Enderlin CA, Beck C, McSweeney JC, Jones TC, Roberson PK. Tailored biobehavioral interventions: a literature review and synthesis. Res Theory Nurs Pract. 2007;21(4):271-85. doi: 10.1891/088971807782428029.

    PMID: 18236771BACKGROUND
  • Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010 Jun 1;152(11):726-32. doi: 10.7326/0003-4819-152-11-201006010-00232. Epub 2010 Mar 24.

    PMID: 20335313BACKGROUND
  • Snijder MB, Dekker JM, Visser M, Yudkin JS, Stehouwer CD, Bouter LM, Heine RJ, Nijpels G, Seidell JC. Larger thigh and hip circumferences are associated with better glucose tolerance: the Hoorn study. Obes Res. 2003 Jan;11(1):104-11. doi: 10.1038/oby.2003.18.

    PMID: 12529492BACKGROUND
  • Tsai MH, Hsu CY, Lin MY, Yen MF, Chen HH, Chiu YH, Hwang SJ. Incidence, Prevalence, and Duration of Chronic Kidney Disease in Taiwan: Results from a Community-Based Screening Program of 106,094 Individuals. Nephron. 2018;140(3):175-184. doi: 10.1159/000491708. Epub 2018 Aug 23.

    PMID: 30138926BACKGROUND
  • Walker SN, Sechrist KR, Pender NJ. The Health-Promoting Lifestyle Profile: development and psychometric characteristics. Nurs Res. 1987 Mar-Apr;36(2):76-81.

    PMID: 3644262BACKGROUND
  • Wen SL, Li J, Wang AN, Lv MM, Li HY, Lu YF, Zhang JP. Effects of transtheoretical model-based intervention on the self-management of patients with an ostomy: A randomised controlled trial. J Clin Nurs. 2019 May;28(9-10):1936-1951. doi: 10.1111/jocn.14731. Epub 2019 Feb 18.

    PMID: 30549366BACKGROUND
  • Yang S, Li M, Chen Y, Zhao X, Chen X, Wang H, Tian Y, Liu C, Shen C. Comparison of the Correlates Between Body Mass Index, Waist Circumference, Waist-to-Height Ratio, and Chronic Kidney Disease in a Rural Chinese Adult Population. J Ren Nutr. 2019 Jul;29(4):302-309.e1. doi: 10.1053/j.jrn.2018.10.008. Epub 2018 Dec 21.

    PMID: 30581064BACKGROUND
  • Zhu LX, Ho SC, Sit JW, He HG. The effects of a transtheoretical model-based exercise stage-matched intervention on exercise behavior in patients with coronary heart disease: a randomized controlled trial. Patient Educ Couns. 2014 Jun;95(3):384-92. doi: 10.1016/j.pec.2014.03.013. Epub 2014 Mar 29.

    PMID: 24726785BACKGROUND
  • Teng HL, Yen M, Fetzer S. Health promotion lifestyle profile-II: Chinese version short form. J Adv Nurs. 2010 Aug;66(8):1864-73. doi: 10.1111/j.1365-2648.2010.05353.x. Epub 2010 Jun 16.

  • Teng HL, Yen M, Fetzer S, Sung JM, Hung SY. Effects of targeted interventions on lifestyle modifications of chronic kidney disease patients: randomized controlled trial. West J Nurs Res. 2013 Oct;35(9):1107-27. doi: 10.1177/0193945913486202. Epub 2013 Apr 25.

  • Yen M, Huang JJ, Teng HL. Education for patients with chronic kidney disease in Taiwan: a prospective repeated measures study. J Clin Nurs. 2008 Nov;17(21):2927-34. doi: 10.1111/j.1365-2702.2008.02348.x.

MeSH Terms

Conditions

Renal Insufficiency, ChronicHealth Behavior

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Limitations and Caveats

The data are not representative of all CKD patients, as the study sample had a male overrepresentation and the subjects were all in stages 1-3.

Results Point of Contact

Title
Miaofen Yen, PhD, RN, FAAN
Organization
National Cheng Kung University

Study Officials

  • Miaofen Yen, Doctor

    National Cheng Kung University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, RN, FAAN

Study Record Dates

First Submitted

August 31, 2010

First Posted

September 3, 2010

Study Start

August 1, 2010

Primary Completion

July 1, 2013

Study Completion

October 1, 2013

Last Updated

May 28, 2026

Results First Posted

May 28, 2026

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

De-identified individuals participants data for all primary and secondary outcome measures.

Locations